These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 15848559

  • 1. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
    Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, Hariharan S, Pirsch J, Matas A, Zaltzman J, Wisemandle K, Fitzsimmons W, First MR.
    Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
    [Abstract] [Full Text] [Related]

  • 2. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
    Florman S, Alloway R, Kalayoglu M, Lake K, Bak T, Klein A, Klintmalm G, Busque S, Brandenhagen D, Lake J, Wisemandle K, Fitzsimmons W, First MR.
    Transplant Proc; 2005 Mar; 37(2):1211-3. PubMed ID: 15848672
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    van Hooff J, Van der Walt I, Kallmeyer J, Miller D, Dawood S, Moosa MR, Christiaans M, Karpf C, Undre N.
    Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
    [Abstract] [Full Text] [Related]

  • 4. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
    Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, Hariharan S, Pirsch J, Matas A, Zaltzman J, Wisemandle K, Fitzsimmons W, First MR.
    Transplantation; 2007 Jun 27; 83(12):1648-51. PubMed ID: 17589351
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y, Hama K, Katayama H, Soga A, Toraishi T, Yokoyama T, Kihara Y, Jojima Y, Konno O, Iwamoto H, Takeuchi H, Hirano T, Shimazu M.
    Transplant Proc; 2012 Jan 27; 44(1):124-7. PubMed ID: 22310595
    [Abstract] [Full Text] [Related]

  • 6. Three-month experience with tacrolimus once-daily regimen in stable renal allografts.
    Diez Ojea B, Alonso Alvarez M, Aguado Fernández S, Baños Gallardo M, García Melendreras S, Gómez Huertas E.
    Transplant Proc; 2009 Jan 27; 41(6):2323-5. PubMed ID: 19715908
    [Abstract] [Full Text] [Related]

  • 7. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
    Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR.
    Transplantation; 2007 Jun 27; 83(12):1639-42. PubMed ID: 17589349
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    Alloway R, Vanhaecke J, Yonan N, White M, Haddad H, Rábago G, Tymchak W, Diaz Molina B, Grimm M, Eiskjaer H, Karpf C, Undre N.
    J Heart Lung Transplant; 2011 Sep 27; 30(9):1003-10. PubMed ID: 21493098
    [Abstract] [Full Text] [Related]

  • 9. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
    Alloway RR, Eckhoff DE, Washburn WK, Teperman LW.
    Liver Transpl; 2014 May 27; 20(5):564-75. PubMed ID: 24493215
    [Abstract] [Full Text] [Related]

  • 10. Modified release tacrolimus.
    First MR, Fitzsimmons WE.
    Yonsei Med J; 2004 Dec 31; 45(6):1127-31. PubMed ID: 15627307
    [Abstract] [Full Text] [Related]

  • 11. First clinical experience with the new once-daily formulation of tacrolimus.
    First MR.
    Ther Drug Monit; 2008 Apr 31; 30(2):159-66. PubMed ID: 18367975
    [Abstract] [Full Text] [Related]

  • 12. Once-daily tacrolimus in living donor liver transplant recipients.
    Sugawara Y, Miyata Y, Kaneko J, Tamura S, Aoki T, Sakamoto Y, Hasegawa K, Yamashiki N, Kokudo N.
    Biosci Trends; 2011 Aug 31; 5(4):156-8. PubMed ID: 21914950
    [Abstract] [Full Text] [Related]

  • 13. Conversion to tacrolimus extended-release formulation: short-term clinical results.
    Gallego-Valcarce E, Ortega-Cerrato A, Llamas-Fuentes F, Martinez-Fernandez G, Perez-Martinez J, Gomez-Roldan C.
    Transplant Proc; 2009 Aug 31; 41(6):2326-7. PubMed ID: 19715909
    [Abstract] [Full Text] [Related]

  • 14. De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.
    Crespo M, Mir M, Marin M, Hurtado S, Estadella C, Gurí X, Rap O, Moral R, Puig JM, Lloveras J.
    Transplant Proc; 2009 Aug 31; 41(6):2115-7. PubMed ID: 19715848
    [Abstract] [Full Text] [Related]

  • 15. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
    Comuzzi C, Lorenzin D, Rossetto A, Faraci MG, Nicolini D, Garelli P, Bresadola V, Toniutto P, Soardo G, Baroni GS, Adani GL, Risaliti A, Baccarani U.
    Transplant Proc; 2010 May 31; 42(4):1320-1. PubMed ID: 20534291
    [Abstract] [Full Text] [Related]

  • 16. Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.
    Meçule A, Poli L, Nofroni I, Bachetoni A, Tinti F, Umbro I, Barile M, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2010 May 31; 42(4):1317-9. PubMed ID: 20534290
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
    Saint-Marcoux F, Debord J, Undre N, Rousseau A, Marquet P.
    Ther Drug Monit; 2010 Apr 31; 32(2):129-35. PubMed ID: 20110850
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial.
    Wlodarczyk Z, Ostrowski M, Mourad M, Krämer BK, Abramowicz D, Oppenheimer F, Miller D, Dickinson J, Undre N.
    Ther Drug Monit; 2012 Apr 31; 34(2):143-7. PubMed ID: 22406656
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D, Noppakun K, Rojanasthien N, Kanchanarattanakorn K, Jittikanont S, Manoyot A, Bunnachak D, Ophascharoensuk V.
    J Med Assoc Thai; 2006 Aug 31; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [Abstract] [Full Text] [Related]

  • 20. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE, Tett SE.
    Clin Pharmacokinet; 2015 Oct 31; 54(10):993-1025. PubMed ID: 26038096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.